DE19732774A1 - Covalent modification of compounds in liquid phase used as e.g. injectable immunogens, contact lenses or catheters - Google Patents
Covalent modification of compounds in liquid phase used as e.g. injectable immunogens, contact lenses or cathetersInfo
- Publication number
- DE19732774A1 DE19732774A1 DE19732774A DE19732774A DE19732774A1 DE 19732774 A1 DE19732774 A1 DE 19732774A1 DE 19732774 A DE19732774 A DE 19732774A DE 19732774 A DE19732774 A DE 19732774A DE 19732774 A1 DE19732774 A1 DE 19732774A1
- Authority
- DE
- Germany
- Prior art keywords
- compounds
- vinyl
- injectable
- groups
- liquid phase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 150000001875 compounds Chemical class 0.000 title claims abstract description 34
- 239000007791 liquid phase Substances 0.000 title claims abstract description 13
- 230000004048 modification Effects 0.000 title claims abstract description 5
- 238000012986 modification Methods 0.000 title claims abstract description 5
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 claims abstract description 29
- 239000007787 solid Substances 0.000 claims abstract description 20
- 125000000524 functional group Chemical group 0.000 claims abstract description 16
- 229920002554 vinyl polymer Polymers 0.000 claims abstract description 16
- 125000004369 butenyl group Chemical group C(=CCC)* 0.000 claims abstract description 14
- 238000000034 method Methods 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- 238000006243 chemical reaction Methods 0.000 claims description 9
- 239000008280 blood Substances 0.000 claims description 7
- 210000004369 blood Anatomy 0.000 claims description 7
- 239000000463 material Substances 0.000 claims description 7
- 239000003814 drug Substances 0.000 claims description 5
- 230000002163 immunogen Effects 0.000 claims description 5
- 108090000623 proteins and genes Proteins 0.000 claims description 4
- 239000013543 active substance Substances 0.000 claims description 3
- 229940124597 therapeutic agent Drugs 0.000 claims description 3
- 230000028327 secretion Effects 0.000 claims description 2
- 239000002689 soil Substances 0.000 claims description 2
- 210000002700 urine Anatomy 0.000 claims description 2
- 239000012530 fluid Substances 0.000 claims 1
- 239000000203 mixture Substances 0.000 abstract description 2
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 abstract 1
- 229910052710 silicon Inorganic materials 0.000 abstract 1
- 239000010703 silicon Substances 0.000 abstract 1
- 239000002245 particle Substances 0.000 description 24
- 239000000243 solution Substances 0.000 description 18
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 9
- -1 e.g. B. glycine Chemical class 0.000 description 7
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 6
- 238000007792 addition Methods 0.000 description 6
- 239000008367 deionised water Substances 0.000 description 6
- 239000007790 solid phase Substances 0.000 description 6
- UFHILTCGAOPTOV-UHFFFAOYSA-N tetrakis(ethenyl)silane Chemical compound C=C[Si](C=C)(C=C)C=C UFHILTCGAOPTOV-UHFFFAOYSA-N 0.000 description 6
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 5
- 229930006000 Sucrose Natural products 0.000 description 5
- 238000000465 moulding Methods 0.000 description 5
- 239000005720 sucrose Substances 0.000 description 5
- 229920002307 Dextran Polymers 0.000 description 4
- 238000004132 cross linking Methods 0.000 description 4
- 239000006185 dispersion Substances 0.000 description 4
- 229920002379 silicone rubber Polymers 0.000 description 4
- 239000004945 silicone rubber Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- VMAWODUEPLAHOE-UHFFFAOYSA-N 2,4,6,8-tetrakis(ethenyl)-2,4,6,8-tetramethyl-1,3,5,7,2,4,6,8-tetraoxatetrasilocane Chemical compound C=C[Si]1(C)O[Si](C)(C=C)O[Si](C)(C=C)O[Si](C)(C=C)O1 VMAWODUEPLAHOE-UHFFFAOYSA-N 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- RWCCWEUUXYIKHB-UHFFFAOYSA-N benzophenone Chemical compound C=1C=CC=CC=1C(=O)C1=CC=CC=C1 RWCCWEUUXYIKHB-UHFFFAOYSA-N 0.000 description 3
- 239000012965 benzophenone Substances 0.000 description 3
- NKSJNEHGWDZZQF-UHFFFAOYSA-N ethenyl(trimethoxy)silane Chemical compound CO[Si](OC)(OC)C=C NKSJNEHGWDZZQF-UHFFFAOYSA-N 0.000 description 3
- 230000007062 hydrolysis Effects 0.000 description 3
- 238000006460 hydrolysis reaction Methods 0.000 description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000011148 porous material Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- KWOLFJPFCHCOCG-UHFFFAOYSA-N Acetophenone Chemical compound CC(=O)C1=CC=CC=C1 KWOLFJPFCHCOCG-UHFFFAOYSA-N 0.000 description 2
- 102000009027 Albumins Human genes 0.000 description 2
- 108010088751 Albumins Proteins 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 239000005909 Kieselgur Substances 0.000 description 2
- 239000004372 Polyvinyl alcohol Substances 0.000 description 2
- BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 description 2
- 229920002323 Silicone foam Polymers 0.000 description 2
- 125000003277 amino group Chemical group 0.000 description 2
- QRHCILLLMDEFSD-UHFFFAOYSA-N bis(ethenyl)-dimethylsilane Chemical compound C=C[Si](C)(C)C=C QRHCILLLMDEFSD-UHFFFAOYSA-N 0.000 description 2
- 239000005289 controlled pore glass Substances 0.000 description 2
- ATDGTVJJHBUTRL-UHFFFAOYSA-N cyanogen bromide Chemical compound BrC#N ATDGTVJJHBUTRL-UHFFFAOYSA-N 0.000 description 2
- 239000008151 electrolyte solution Substances 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 2
- 229910052753 mercury Inorganic materials 0.000 description 2
- 239000003504 photosensitizing agent Substances 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 description 2
- 239000000376 reactant Substances 0.000 description 2
- 239000013049 sediment Substances 0.000 description 2
- 238000004062 sedimentation Methods 0.000 description 2
- 229910000077 silane Inorganic materials 0.000 description 2
- 150000004756 silanes Chemical class 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 239000013514 silicone foam Substances 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 229920000856 Amylose Polymers 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- NOWKCMXCCJGMRR-UHFFFAOYSA-N Aziridine Chemical compound C1CN1 NOWKCMXCCJGMRR-UHFFFAOYSA-N 0.000 description 1
- 244000309494 Bipolaris glycines Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 239000000055 Corticotropin-Releasing Hormone Substances 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 241000206672 Gelidium Species 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 102000008100 Human Serum Albumin Human genes 0.000 description 1
- 108091006905 Human Serum Albumin Proteins 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- PWKSKIMOESPYIA-BYPYZUCNSA-N L-N-acetyl-Cysteine Chemical compound CC(=O)N[C@@H](CS)C(O)=O PWKSKIMOESPYIA-BYPYZUCNSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 238000007259 addition reaction Methods 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- ROOXNKNUYICQNP-UHFFFAOYSA-N ammonium persulfate Chemical compound [NH4+].[NH4+].[O-]S(=O)(=O)OOS([O-])(=O)=O ROOXNKNUYICQNP-UHFFFAOYSA-N 0.000 description 1
- 239000012935 ammoniumperoxodisulfate Substances 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 125000003636 chemical group Chemical group 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- IDLFZVILOHSSID-OVLDLUHVSA-N corticotropin Chemical compound C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)NC(=O)[C@@H](N)CO)C1=CC=C(O)C=C1 IDLFZVILOHSSID-OVLDLUHVSA-N 0.000 description 1
- 229960000258 corticotropin Drugs 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- MOTZDAYCYVMXPC-UHFFFAOYSA-N dodecyl hydrogen sulfate Chemical compound CCCCCCCCCCCCOS(O)(=O)=O MOTZDAYCYVMXPC-UHFFFAOYSA-N 0.000 description 1
- 229940043264 dodecyl sulfate Drugs 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000005670 electromagnetic radiation Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- BITPLIXHRASDQB-UHFFFAOYSA-N ethenyl-[ethenyl(dimethyl)silyl]oxy-dimethylsilane Chemical compound C=C[Si](C)(C)O[Si](C)(C)C=C BITPLIXHRASDQB-UHFFFAOYSA-N 0.000 description 1
- WOXXJEVNDJOOLV-UHFFFAOYSA-N ethenyl-tris(2-methoxyethoxy)silane Chemical compound COCCO[Si](OCCOC)(OCCOC)C=C WOXXJEVNDJOOLV-UHFFFAOYSA-N 0.000 description 1
- XSGUVBCHBVUMMR-UHFFFAOYSA-N ethenyl-tris(prop-1-enoxy)silane Chemical compound CC=CO[Si](OC=CC)(OC=CC)C=C XSGUVBCHBVUMMR-UHFFFAOYSA-N 0.000 description 1
- 229910021485 fumed silica Inorganic materials 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 239000005337 ground glass Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 239000003999 initiator Substances 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 210000001589 microsome Anatomy 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 230000006855 networking Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 239000002685 polymerization catalyst Substances 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 239000010453 quartz Substances 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 125000000467 secondary amino group Chemical class [H]N([*:1])[*:2] 0.000 description 1
- 150000003377 silicon compounds Chemical class 0.000 description 1
- RBFZWTMVVUVHLM-UHFFFAOYSA-M sodium;2-[(4-hydroxyphenyl)-(4-oxocyclohexa-2,5-dien-1-ylidene)methyl]benzenesulfonate Chemical compound [Na+].C1=CC(O)=CC=C1C(C=1C(=CC=CC=1)S([O-])(=O)=O)=C1C=CC(=O)C=C1 RBFZWTMVVUVHLM-UHFFFAOYSA-M 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 108010013480 succinylated gelatin Proteins 0.000 description 1
- 229940007079 succinylated gelatin Drugs 0.000 description 1
- YBBRCQOCSYXUOC-UHFFFAOYSA-N sulfuryl dichloride Chemical compound ClS(Cl)(=O)=O YBBRCQOCSYXUOC-UHFFFAOYSA-N 0.000 description 1
- 238000009210 therapy by ultrasound Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- PKRKCDBTXBGLKV-UHFFFAOYSA-N tris(ethenyl)-methylsilane Chemical compound C=C[Si](C)(C=C)C=C PKRKCDBTXBGLKV-UHFFFAOYSA-N 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
- A61L29/04—Macromolecular materials
- A61L29/043—Polysaccharides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
- C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
- C12N11/08—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer
- C12N11/089—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
- A61L29/04—Macromolecular materials
- A61L29/044—Proteins; Polypeptides; Degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/04—Macromolecular materials
- A61L31/042—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/04—Macromolecular materials
- A61L31/043—Proteins; Polypeptides; Degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
- A61L33/0076—Chemical modification of the substrate
- A61L33/0082—Chemical modification of the substrate by reacting with an organic compound other than heparin
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/281—Sorbents specially adapted for preparative, analytical or investigative chromatography
- B01J20/286—Phases chemically bonded to a substrate, e.g. to silica or to polymers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/30—Processes for preparing, regenerating, or reactivating
- B01J20/32—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
- B01J20/3202—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating characterised by the carrier, support or substrate used for impregnation or coating
- B01J20/3206—Organic carriers, supports or substrates
- B01J20/3208—Polymeric carriers, supports or substrates
- B01J20/3212—Polymeric carriers, supports or substrates consisting of a polymer obtained by reactions otherwise than involving only carbon to carbon unsaturated bonds
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/30—Processes for preparing, regenerating, or reactivating
- B01J20/32—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
- B01J20/3231—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating characterised by the coating or impregnating layer
- B01J20/3242—Layers with a functional group, e.g. an affinity material, a ligand, a reactant or a complexing group
- B01J20/3244—Non-macromolecular compounds
- B01J20/3246—Non-macromolecular compounds having a well defined chemical structure
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2220/00—Aspects relating to sorbent materials
- B01J2220/50—Aspects relating to the use of sorbent or filter aid materials
- B01J2220/52—Sorbents specially adapted for preparative chromatography
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2220/00—Aspects relating to sorbent materials
- B01J2220/50—Aspects relating to the use of sorbent or filter aid materials
- B01J2220/54—Sorbents specially adapted for analytical or investigative chromatography
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Surgery (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Hematology (AREA)
- Materials For Medical Uses (AREA)
Abstract
Description
Diese Erfindung betrifft ein Verfahren zur kovalenten Modifizierung von in flüssiger Phase vorliegenden, funktionelle Gruppen enthaltenden Verbindungen sowie die Verwendung der Verfahrensprodukte.This invention relates to a method for the covalent modification of in liquid Phase present, functional group-containing compounds and the Use of the process products.
Unter dem Begriff "funktionelle Gruppen" werden im folgenden chemische Gruppen verstanden, welche sich in bekannter Art und Weise an C-C-Doppelbindungen addieren lassen. Als Beispiele seien -OH, -NH2, -CHO, -CH2-Cl, -SH etc. genannt, siehe hierzu auch Jerry March: Advanced Organic Chemistry, John Wiley & Sons, 3 Auflage, S. 657-779, New York 1985.In the following, the term “functional groups” is understood to mean chemical groups which can be added to CC double bonds in a known manner. Examples include -OH, -NH 2 , -CHO, -CH 2 -Cl, -SH etc., see also Jerry March: Advanced Organic Chemistry, John Wiley & Sons, 3 edition, pp. 657-779, New York 1985.
Als Verbindungen, die derartige funktionelle Gruppen enthalten, seien beispiels weise Monosaccharide, wie z. B. Glucose, Fructose, Mannose, etc. oder Disaccha ride, wie z. B. Saccharose, Lactose, etc. oder Polysaccharide, wie z. B. Stärke, Amylose, Agarose, Dextran, Agar-Agar, Arabinose, Heparin, Alginat, Cellullose, Pectin, etc. oder Aminosäuren, wie z. B. Glycin, Lysin, Arginin, Cystein, etc. oder (Oligo-) Peptide, wie z. B. (gentechnologisch hergestelltes) FSH, LH, ACTH, etc. oder Proteine, wie z. B. Gelantine, Kollagen, Mikrosomen, Plasmide, Enzyme, Anti körper, Rezeptoren etc. ebenso genannt, wie andere chemisch definierte Verbindungen, wie z. B. Pharmaka oder Kunststoffe, z. B. Polyvinylalkohol (PVA).Examples of compounds containing such functional groups are wise monosaccharides, such as. B. glucose, fructose, mannose, etc. or disaccha ride, such as B. sucrose, lactose, etc. or polysaccharides, such as. B. starch, Amylose, agarose, dextran, agar-agar, arabinose, heparin, alginate, cellulose, Pectin, etc. or amino acids such as e.g. B. glycine, lysine, arginine, cysteine, etc. or (Oligo) peptides such as e.g. B. (genetically engineered) FSH, LH, ACTH, etc. or proteins, such as B. gelatin, collagen, microsomes, plasmids, enzymes, anti body, receptors, etc., as well as other chemically defined ones Connections such as B. pharmaceuticals or plastics, e.g. B. Polyvinyl alcohol (PVA).
O.g. Verbindungen liegen dabei in flüssiger, insbesondere physiologisch-wäßriger Phase vor. Als Beispiele seien eine 5 gew.-%ige Glucose-Lösung in de-ionisiertem Wasser, eine 5 gew.-%ige Albumin-Lösung in isotonischer Kochsalz-Lösung, eine 10 gew.-%ige Dextran-Lösung in isotonischer Kochsalzlösung (mittleres Molekular gewicht des Dextran 40.000), eine 20 gew.-%ige Mannit-Lösung in de-ionisiertem Wasser, eine 3 gew.-%ige Lösung eines Polymerisats abgebauter succinylierter Gelantine (mittleres Molekulargewicht 35.000) in isotoner Elektrolyt-Lösung, etc. genannt. O.g. Compounds are in liquid, in particular physiologically aqueous Phase before. Examples are a 5% by weight glucose solution in de-ionized Water, a 5% by weight albumin solution in isotonic saline solution, a 10% by weight dextran solution in isotonic saline (average molecular weight weight of dextran 40,000), a 20% by weight mannitol solution in de-ionized Water, a 3% by weight solution of a polymer degraded succinylated Gelatin (average molecular weight 35,000) in isotonic electrolyte solution, etc. called.
Der hier verwendete Begriff "kovalente Modifizierung" umschreibt, daß o.g. beispielhaft aufgeführten, in flüssiger Phase vorliegenden, funktionelle Gruppen enthaltenden Verbindungen miteinander kovalent vernetzt (engl.: crosslink) oder aber auch kovalent an die Oberflächen von Festkörpern gebunden werden. Das Vernetzen von chemisch definierten Verbindungen untereinander bzw. das Binden derartiger Verbindungen an feste Phasen ist auf dem Gebiet der Biotechnologie und der Biomaterialien bekannt und üblich, siehe hierzu beispielsweise die Kataloge der Fa. PIERCE, USA-Rockford, Illinois. - Durch das kovalente Ver netzen von Verbindungen untereinander, erhalten o.g. Verbindungen beispiels weise höhere Viskositäten und/oder höhere Sedimentationsgeschwindigkeiten und/oder veränderte immunogene Eigenschaften und/oder verändertes (biologisches) Abbauverhalten. Durch kovalente Bindung o.g. Verbindungen an Oberflächen von Festkörnern, bekommen diese neue (Oberflächen-)Eigen schaften: die Anzahl reaktiver Gruppen, die für weitere Reaktionen zur Verfügung stehen, wird erhöht und das (Wasser-)Benetzungsverhalten wird verändert, vorzugsweise verbessert, so daß sich dies seinerseits im Sedimentationsverhalten und in den Fließeigenschaften partikelförmiger Festkörper widerspiegelt.The term "covalent modification" used here describes that the above. functional groups present in the liquid phase as examples containing compounds cross-linked covalently or but also be covalently bound to the surfaces of solids. The Networking of chemically defined compounds with each other or binding such connections to solid phases is in the field of biotechnology and the biomaterials known and common, see for example the PIERCE, USA-Rockford, Illinois catalogs. - By the covalent ver network connections with each other, get the above Connections for example as higher viscosities and / or higher sedimentation rates and / or altered immunogenic properties and / or altered (biological) degradation behavior. Through covalent bonding the above Connections Surfaces of solid particles get this new (surface) property the number of reactive groups available for further reactions stand, is increased and the (water) wetting behavior is changed, preferably improved so that this in turn is reflected in the sedimentation behavior and is reflected in the flow properties of particulate solids.
Bei den bekannten Methoden zur Vernetzung von Verbindungen untereinander bzw. deren Bindung an Oberflächen von dispergierten Festkörpern werden Chemikalien verwendet, die, wie z. B. CNBr, toxisch sind oder, die zu Bindungen führen, die mit einer Halbwertszeit von ca. 18 Stunden, wie bei CDI, nur begrenzt hydrolysestabil sind oder die Reaktionsbedingungen erfordern, wie z. B. Epoxy, wo empfindliche biologisch aktive Verbindungen denaturieren.In the known methods for cross-linking connections or their binding to surfaces of dispersed solids Chemicals used, such as. B. CNBr, are toxic or that lead to bonds lead, with a half-life of approx. 18 hours, as with CDI, only limited are stable to hydrolysis or require the reaction conditions, e.g. B. epoxy where denature sensitive biologically active compounds.
Aufgabe der Erfindung ist es, chemisch definierte, in flüssiger Phase vorliegende, funktionelle Gruppen aufweisende Verbindungen durch den Einsatz bekannter, preiswerter, toxikologisch unbedenklicher Chemikalien, in einfacher Art und Weise und mit großer Effizienz derart miteinander zu vernetzen oder an Oberflächen von Festkörpern zu binden, daß die neu geschaffenen kovalenten Bindungen hydrolysestabil sind und sie auch mittels energiereicher elektromagnetischer Strahlung, z. B. UV, zu erzielen sind und daß die Herstellungsprodukte in einer Vielzahl von Ausbildungen, wie z. B. als Immunogen, Chromatographiematerial oder als Medizinprodukt eingesetzt werden können. The object of the invention is to provide chemically defined liquid phase compounds containing functional groups through the use of known, inexpensive, toxicologically harmless chemicals, in a simple way and to network with each other with great efficiency or on surfaces of To bind solids that the newly created covalent bonds are stable to hydrolysis and also by means of high-energy electromagnetic Radiation, e.g. B. UV, can be achieved and that the products in one Variety of training, such as B. as an immunogen, chromatography material or can be used as a medical device.
Die Aufgabe wird dadurch gelöst, daß man chemisch definierte, in flüssiger Phase vorliegende, funktionelle Gruppen aufweisende Verbindungen mit anderen Verbindungen oder mit Festkörpern, die mindestens zwei siliziumgebundene Vinyl- oder Butenylgruppen pro Molekül bzw. auf der Festkörperoberfläche aufweisen, derart miteinander in innigen Kontakt bringt und Reaktionsbedingungen aussetzt, daß die funktionellen Gruppen der erstgenannten Verbindungen an die Vinyl- bzw. Butenylgruppen der zweitgenannten Verbindungen oder der Festkörper addiert werden.The object is achieved by chemically defined, in the liquid phase present functional group connections with others Compounds or with solids containing at least two silicon-bonded vinyl or have butenyl groups per molecule or on the solid surface, bringing them into intimate contact and exposing them to reaction conditions, that the functional groups of the first-mentioned compounds are attached to the vinyl or Butenyl groups of the second-mentioned compounds or the solids added become.
Verbindungen, die mindestens zwei siliziumgebundene Vinyl- oder Butenylgruppen pro Molekül aufweisen, sind bekannt. Als Beispiele seien Tetravinylsilan, 1,3-Divinyl-tetramethyldisiloxan, Methyltrivinylsilan, Dimethyldivinylsilan, Tetra methyltetravinylcyclotetrasiloxan; vinylendgestoppte, lineare Polydimethylsiloxane; vinylgruppen-haltige Polymethylsiloxane mit end- und seitenständigen Vinyl gruppen etc. genannt.Compounds that have at least two silicon-bonded vinyl or butenyl groups have per molecule are known. Examples include tetravinylsilane, 1,3-divinyl-tetramethyldisiloxane, methyltrivinylsilane, dimethyldivinylsilane, tetra methyltetravinylcyclotetrasiloxane; vinyl end-capped linear polydimethylsiloxanes; vinyl group-containing polymethylsiloxanes with terminal and pendant vinyl called groups etc.
Festkörper, die mindestens zwei siliziumgebundene Vinyl- oder Butenylgruppen auf der Festkörperoberfläche aufweisen, sind ebenfalls bekannt bzw. können leicht geschaffen werden. Als Beispiele seien mit Vinyl- oder Butenylgruppen ober flächen-modifizierte hochdisperse Kieselsäure (engl: fumed silica), gemahlenes Glas, offen-poriges Glas, z. B. Siran®, Bioran® oder controlled pore glass (CPG), Kieselgur, (Ouarz-) Sand, zu Partikeln zermahlene Formkörper aus Silikon kautschuk oder offen-poriger Silikonschaum ebenso genannt, wie fertig aus gebildete Formkörper aus Silikonkautschuk, wie z. B. Kontaktlinsen, Intra okularlinsen, (Blut-)Katheter, (Mamma-)Implantate etc. Diese jeweils mit Vinyl- oder Butenylgruppen oberflächenmodifizierten Partikel bzw. Formkörper sind bei spielsweise leicht dadurch zu erhalten, daß man in Anlehnung an Weethall, H.H.: Covalent Coupling Methods for Inorganic Support Materials in Methods in Enzymology (K. Mosbach, ed.), Vol. XLIV, pp 134-148 (1976), Academic Press, New York, die Partikel- bzw. Formkörperoberfläche, anstatt mit einem amino gruppen-haltigen Silan, sie jetzt mit einem vinylgruppen-haltigen Silan, wie z. B. Vinyltriaethoxysilan, Vinyltrimethoxysilan, Vinytriacetoxysilan, Vinyltripropenoxy silan, Vinyl-tris-(2-methoxyaethoxy)-silan odgl. oberflächenmodifiziert. Bevorzugte Partikel bzw. Formkörper weisen eine zwischen 0,9 und 1,3 g/ml liegende Dichte auf, haben einen zwischen 5 nm und mehreren Millimetern liegenden Partikel durchmesser, sind porös, sind biologisch inert und sind mit oben erwähnten vinyl- oder butenylgruppen-haltigen Silanen leicht oberflächen zu modifizieren.Solids that have at least two silicon-bonded vinyl or butenyl groups the solid surface are also known or can easily be created. Examples include vinyl or butenyl groups surface-modified highly disperse silica (fumed silica), ground Glass, open-pore glass, e.g. B. Siran®, Bioran® or controlled pore glass (CPG), Diatomaceous earth, (Ouarz-) sand, molded particles made of silicone rubber or open-pore silicone foam as well as finished Molded body made of silicone rubber, such as. B. contact lenses, intra eyepiece lenses, (blood) catheters, (mamma) implants etc. These each with vinyl or butenyl group-modified particles or moldings are included easily obtainable, for example, by following Weethall, H.H .: Covalent Coupling Methods for Inorganic Support Materials in Methods in Enzymology (K. Mosbach, ed.), Vol. XLIV, pp 134-148 (1976), Academic Press, New York, the particle or shaped body surface, instead of with an amino group-containing silane, they now with a vinyl group-containing silane, such as. B. Vinyltriaethoxysilane, vinyltrimethoxysilane, vinytriacetoxysilane, vinyltripropenoxy silane, vinyl tris (2-methoxyethoxy) silane or the like. surface modified. Preferred Particles or moldings have a density of between 0.9 and 1.3 g / ml have a particle between 5 nm and several millimeters diameters, are porous, are biologically inert and are covered with the above-mentioned vinyl or to modify butenyl group-containing silanes easily.
Die erfindungsgemäße Vernetzung hydroxylgruppen-haltiger Verbindungen mittels
Divinyldimethylsilan läßt sich formelmäßig folgendermaßen beschreiben:
The crosslinking of hydroxyl-containing compounds according to the invention by means of divinyldimethylsilane can be described in terms of the formula:
Die erfindungsgemäße Bindung aminogruppen-haltiger Verbindungen an partikel-
bzw. formkörperoberflächen-ständigen Vinylgruppen läßt sich formelmäßig
folgendermaßen beschreiben:
The bond according to the invention of compounds containing amino groups to vinyl groups which are in the form of particles or mold surfaces can be described in terms of the formula:
Die durch Addition von funktionellen Gruppen, wie z. B. -OH, -NH2, -CHO, -COOH, -CH2-Cl,. . .-SH, an C-C-Doppelbindungen erhaltenen Ether-, sekundären Amin-, Ester-, Alkyl-. . . Sulfidbindungen gelten im Vergleich zum Stand der Technik als äußerst hydrolysestabil.The addition of functional groups, such as. B. -OH, -NH 2 , -CHO, -COOH, -CH 2 -Cl ,. . .-SH, ether, secondary amine, ester, alkyl obtained on CC double bonds. . . Compared to the prior art, sulfide bonds are considered to be extremely stable to hydrolysis.
Das in-innigen-Kontakt-bringen der in flüssiger Phase vorliegenden, funktionelle Gruppen enthaltenden Verbindungen mit Verbindungen, die mindestens zwei siliziumgebundene Vinyl- oder Butenylgruppen pro Molekül enthalten, erfolgt in der Regel durch einfaches Vermischen der Reaktanten miteinander. Da vinyl- oder butenylgruppenhaltige Siliziumverbindungen schlecht wasserlöslich sind, muß man nach Lösemittelsysteme suchen, worin sowohl hydrophile als auch hydrophobe Verbindungen wenigstens teilweise zu lösen sind. Die geeignete Auswahl solcher Systeme ist dem Fachmann geläufig: beispielsweise kann man hydroxylgruppen haltige Verbindungen mit vinylgruppen-haltigen Silanen bzw. vinylgruppen-haltigen niedermolekularen Siloxanen in wäßrig-alkoholischen Lösungen, z. B. 3 Teile 2-Propanol und 1 Teil Wasser auch ohne die Verwendung von oberflächenaktiven Substanzen, wie z. B. Tensiden, in einem Homogenisator ausreichend gut emulgieren.The intimate contact of the functional liquid phase Group-containing compounds with compounds that have at least two contain silicon-bonded vinyl or butenyl groups per molecule takes place in the Usually by simply mixing the reactants together. Because vinyl or Silicon compounds containing butenyl groups are poorly water-soluble, one must look for solvent systems in which both hydrophilic and hydrophobic Connections are at least partially to be solved. The appropriate selection of such Systems are familiar to the person skilled in the art: for example, hydroxyl groups containing compounds with vinyl groups-containing silanes or vinyl group-containing low molecular weight siloxanes in aqueous alcoholic solutions, e.g. B. 3 parts 2-propanol and 1 part water even without the use of surfactants Substances such as B. surfactants, sufficiently good in a homogenizer emulsify.
Das in-innigen-Kontakt-bringen der in flüssiger Phase vorliegenden, funktionelle Gruppen enthaltenden Verbindungen mit Partikeln bzw. Formkörpern, die mindestens zwei siliziumgebundene Vinyl- oder Butenylgruppen auf der Partikel- bzw. Formkörperoberfläche aufweisen, geschieht problemlos durch Einrühren der Partikel in die flüssige Phase bzw. durch Kontaktieren der Formkörper mit der flüssigen Phase. Dabei kann das Anfeuchten von vinylgruppen-haltigen Partikeln mit einem niederaliphatischen Alkohol deren Dispergierung erleichtern.The intimate contact of the functional liquid phase Group-containing compounds with particles or moldings that at least two silicon-bonded vinyl or butenyl groups on the particle or have molded surface, is easily done by stirring in Particles in the liquid phase or by contacting the molded body with the liquid phase. The moistening of vinyl group-containing particles with a lower aliphatic alcohol to facilitate their dispersion.
Die Reaktionsbedingungen, bei denen die funktionellen Gruppen der in flüssiger Phase vorliegenden Verbindungen an die Vinyl- oder Butenylgruppen der anderen Verbindungen, Partikel oder Formkörper addiert werden, sind dem Fachmann geläufig. Sie werden im Hinblick auf den Einsatzzweck der zu vernetzenden bzw. an eine Festkörperoberfläche zu bindenden Verbindungen, unter Berücksichtigung der Natur der jeweiligen funktionellen Gruppe, ihrer auf das Molekulargewicht bzw. auf die Festkörperoberfläche bezogenen Konzentration, der Konzentrationen der einzelnen Reaktanten, der chemischen Natur des Lösungsmittel(gemischs), des pH der Reaktionslösung, der Reaktionstemperatur, Art und Konzentration zugesetzter Katalysatoren und/oder Initiatoren und/oder Photosensibilisatoren jeweils experimentell ermittelt und optimiert.The reaction conditions under which the functional groups are in liquid Phase present compounds on the vinyl or butenyl groups of the others Connections, particles or moldings are added to the person skilled in the art common. With regard to the intended use of the networked or connections to be bound to a solid surface, taking into account the nature of the respective functional group, its molecular weight or concentration related to the solid surface, the concentrations of the individual reactants, the chemical nature of the solvent (mixture), the pH of the reaction solution, the reaction temperature, type and concentration added catalysts and / or initiators and / or photosensitizers each experimentally determined and optimized.
Als Faustregel gilt: sollen empfindliche, in flüssiger Phase vorliegende, funktionelle Gruppen enthaltende Verbindungen, wie z. B. biologisch aktive Substanzen, z. B. native Enzyme, Rezeptoren oder Antikörper miteinander vernetzt oder an Fest körperoberflächen gebunden werden, so wählt man die Reaktionsbedingungen möglichst milde. "Möglichst milde" bedeutet, daß die eingesetzten Lösemittel und deren pH und Temperatur nicht denaturierend wirken und daß die Additions reaktion vorzugsweise durch Photosensibilisatoren, wie z. B. Benzophenon oder Acetophenon, und UV-Licht initiert wird. - Werden hingegen relativ unempfindliche Verbindungen, wie z. B. Saccharide miteinander vernetzt bzw. an eine Festkörper oberfläche gebunden, führt man vorteilhaft die Additionsreaktion bei erhöhtem Druck und erhöhter Temperatur unter Verwendung von Polymerisations katalysatoren, z. B. wasserlöslichen Peroxiden, durch.As a rule of thumb: sensitive, functional, liquid phase should be used Group-containing compounds, such as. B. biologically active substances, e.g. B. native enzymes, receptors or antibodies cross-linked or on solid body surfaces are bound, so you choose the reaction conditions as mild as possible. "As mild as possible" means that the solvents and whose pH and temperature do not have a denaturing effect and that the additions reaction preferably by photosensitizers, such as. B. benzophenone or Acetophenone, and UV light is initiated. - However, become relatively insensitive Connections such as B. cross-linked saccharides or to a solid bound to the surface, the addition reaction is advantageously carried out with increased Pressure and elevated temperature using polymerization catalysts, e.g. B. water-soluble peroxides.
Die mittels dieses Verfahrens kovalent miteinander vernetzten Verbindungen werden als injizierbares Immunogen, als injizierbares (Genprodukt-) Therapeutikum, als injizierbarer Arzneimittelträger, als Ausgangsmaterial für (affinitäts-)chromatographische Zwecke etc. eingesetzt. - Verfahrensprodukte, die durch Addition von funktionelle Gruppen aufweisenden Verbindungen an vinyl gruppen-haltige Partikeloberflächen geschaffen wurden, werden als (injizierbares) Immunogen, als (injizierbares) (Genprodukt-)Therapeutikum, als Ausgangsmaterial zur Immobilisierung von biologisch aktiven Substanzen, als (Basis-) Material für chromatographische Zwecke, etc. eingesetzt. - Verfahrensprodukte, die durch Addition von funktionelle Gruppen aufweisenden Verbindungen an vinylgruppen haltige Formkörperoberflächen geschaffen wurden, werden als mit Blut, Tränen flüssigkeit, Sekret, Urin, zellhaltigem Gewebe, etc. in Kontakt kommende Medizin produkten, wie z. B. Blutbeuteln, Kontaktlinsen oder (Blut-)Katheter oder als wasserbindende Materialien zur Erdbodenlockerung oder als. . . eingesetzt.The compounds covalently cross-linked by this method are used as an injectable immunogen, as an injectable (gene product) Therapeutic agent, as an injectable drug carrier, as a starting material for (affinity) chromatographic purposes etc. used. - Process products that by adding functional group-containing compounds to vinyl group-containing particle surfaces have been created are (injectable) Immunogen, as an (injectable) (gene product) therapeutic agent, as starting material for the immobilization of biologically active substances, as (basic) material for chromatographic purposes, etc. used. - Process products by Addition of functional group-containing compounds to vinyl groups Molded surfaces containing created are considered to be with blood, tears liquid, secretions, urine, cell-containing tissue, etc. contacting medicine products such as B. blood bags, contact lenses or (blood) catheters or as water-binding materials for soil loosening or as. . . used.
50 ml Rheofusin® (Fa. Kabi Pharmacia), welches mit 1 M HCl auf pH 2 angesäuert wurde, werden mit 2 ml einer 10 vol.-%igen Lösung von Tetramethyltetravinyl cyclotetrasiloxan in Methanol, welcher ein Spatelspitze Benzophenon zugesetzt wurde, bei Raumtemperatur über 48 Stunden und bei Bestrahlung mit einem Quecksilber-Mitteldruckstrahler in einem rotierenden Rundkolben kontaktiert. - Deutliche Unterschiede im Lösungsverhalten zeigen sich, wenn man jeweils gleiche Volumina des so hergestellten Produkts bzw. von nativen Rheofusin® in 2-Propanol eintropft. 50 ml Rheofusin® (from Kabi Pharmacia), which is acidified to pH 2 with 1 M HCl was with 2 ml of a 10 vol .-% solution of tetramethyltetravinyl cyclotetrasiloxane in methanol, which added a spatula tip of benzophenone was at room temperature for 48 hours and when irradiated with a Medium-pressure mercury lamps in a rotating round-bottom flask contacted. - There are clear differences in the behavior when solving each equal volumes of the product thus produced or of native Rheofusin® in Drops of 2-propanol.
50 ml einer 5%igen Lösung von Albumin in einer Elektrolyt-Lösung (Fa. Immuno) werden mit 5 ml einer 5 vol.-%igen Tetravinylsilan-Emulsion in de-ionisiertem Wasser wie bei Beispiel 1 beschrieben kontaktiert. - Die Tetravinylsilan-Emulsion wurde durch Zugabe von 5 vol-% Tetravinylsilan und 0,5 gew.-% Na-dodecylsulfat zu kochendem Wasser und ca. 2 minütiger Ultraschallbehandlung hergestellt. - Unterschiede im Lösungsverhalten zeigen sich beim Zutropfen gleicher Volumina von unvernetzten und mittels Tetravinylsilan vernetzten Albumin zu isotonischer Kochsalzlösung, welche 2,5 Vol.-% 96%igen Ethanol enthält.50 ml of a 5% solution of albumin in an electrolyte solution (from Immuno) be with 5 ml of a 5 vol .-% tetravinylsilane emulsion in de-ionized Contacted water as described in Example 1. - The tetravinyl silane emulsion was by adding 5 vol% tetravinylsilane and 0.5 wt .-% Na dodecyl sulfate to boiling water and about 2 minutes of ultrasound treatment. - Differences in the solution behavior are evident when dropping the same volumes from uncrosslinked and crosslinked by means of tetravinylsilane to isotonic Saline solution, which contains 2.5 vol .-% 96% ethanol.
Das Ausrüsten der Oberflächen der Partikel mit siliziumgebundenen Vinylgruppen erfolgte durch mehrtägiges Kontaktieren von offen-porigen Glas (Siran®), offen porigem Silikonschaum (gemäß DE-OS 195 42 687 hergestellt), Kieselgur (DIAMOL GM®, Fa. Franz Bertram GmbH, Hamburg), hochdisperser Kieselsäure (HDK T 30, Fa. Wacker-Chemie GmbH, Burghausen) und Silikonpartikeln, die durch Zermahlen von Silikonformkörpern unter Verwendung von flüssigem Stickstoff auf eine Korngröße von <800 µm gewonnen wurden, mit einer 10 vol.-%igen Vinyltnmethoxysilan-Lösung in Methanol, pH 2, anschließendem mehrstündigen Trocknen der Partikel bei ca. 50°C und abschließendem Waschen mit einer aus 1 Teil Methanol und 1 Teil de-ionisiertem Wasser bestehenden Waschlösung, deren pH mit HCl auf ca. 2 eingestellt war. - Ca. 1 Volumenteil der jeweiligen, nunmehr vinylgruppen-haltigen Festphasepartikel wurden dann im waschflüssigkeitsfeuchten Zustand in ca. 10 Volumenteilen einer 5 gew.-%igen wäßrigen Saccharose-Lösung, pH 2, dispergiert. Zu den jeweiligen Dispersionen wurden dann ca. 3 Gew.-% Ammoniumperoxodisulfat zugesetzt, bevor die Dispersionen dann für 45 min bei 121°C und 1,2 bar autoklaviert wurden. Danach wurden die Dispersionen mehrmals mit de-ionisierten Wasser gewaschen und im feuchten Zustand aufbewahrt. - Alle derart mit Saccharose oberflächen modifizierten Festphasepartikel sedimentieren in Wasser deutlich schneller als die entsprechenden unbehandelten Partikel. - An diese derart kovalent gebundenen Hydroxylgruppen dieser Partikel können in einem zweiten Schritt nunmehr biologisch aktive Verbindungen, z. B. Antikörper oder Enzyme, mittels etablierter Methoden, wie z. B. CNBr, CDI, Sulfonylchlorid oder FMP, gebunden werden.Equipping the surfaces of the particles with silicon-bonded vinyl groups was carried out by contacting open-pore glass (Siran®) for several days, open porous silicone foam (manufactured according to DE-OS 195 42 687), diatomaceous earth (DIAMOL GM®, Franz Bertram GmbH, Hamburg), highly disperse silica (HDK T 30, Wacker-Chemie GmbH, Burghausen) and silicone particles, the by grinding silicone moldings using liquid Nitrogen to a grain size of <800 microns were obtained with a 10 vol .-% Vinyltnmethoxysilan solution in methanol, pH 2, then Drying the particles at approx. 50 ° C for several hours and then washing them with one consisting of 1 part methanol and 1 part de-ionized water Wash solution, the pH of which was adjusted to about 2 with HCl. - Approx. 1 part by volume of respective, now vinyl group-containing solid phase particles were then in washing liquid-moist state in approx. 10 parts by volume of a 5% by weight aqueous sucrose solution, pH 2, dispersed. About the respective dispersions about 3% by weight of ammonium peroxodisulfate were then added before the Dispersions were then autoclaved for 45 min at 121 ° C and 1.2 bar. After that the dispersions were washed several times with deionized water and in stored in a moist state. - All surfaces with sucrose modified solid phase particles sediment much faster in water than that corresponding untreated particles. - To these so covalently bound Hydroxyl groups of these particles can now in a second step biologically active compounds, e.g. B. antibodies or enzymes, by means of established Methods such as B. CNBr, CDI, sulfonyl chloride or FMP.
Im wesentlichen gleiches Vorgehen wie in Beispiel 3 beschrieben: anstatt einer 5 gew.-%igen Saccharose-Lösung wird aber eine 2 gew.-%ige Ethylenimin polymer-Lösung (Fa. Fluka, Neu-Ulm), in de-ionisiertem Wasser, pH 11, eingesetzt. - Alle derart mit Polymin POR oberflächen-modifizierten Festphase partikel sedimentieren in Wasser deutlich schneller als die entsprechenden unbehandelten Partikel, weiterhin binden sie in Wasser gelöste anionische Farbstoffe, z. B. "Phenolrotwasserlöslich" (Fa. Fluka, Neu-Ulm).Essentially the same procedure as described in Example 3: instead of one 5% by weight sucrose solution becomes a 2% by weight ethyleneimine polymer solution (from Fluka, Neu-Ulm), in de-ionized water, pH 11, used. - All solid phase modified with Polymin POR particles sediment much faster in water than the corresponding ones untreated particles, they also bind anionic dissolved in water Dyes, e.g. B. "Phenol red water soluble" (Fa. Fluka, Neu-Ulm).
Kontaktlinsen aus Silikonkautschuk (Fa. Wöhlk, Schönkirchen bei Kiel) wurden für ca. 8 Tage gasförmigen Vinyltrimethoxysilan ausgesetzt und zwar dadurch, daß sie bei 30°C in einem Netz aus Polypropylen oberhalb von ca. 10 ml Vinyl trimethoxysilan in einem Exsikkator positioniert waren. Die Kontaktlinsen wurden danach einer ca. zweistündigen Wärmebehandlung bei ca. 70°C unterzogen. Danach wurden sie in Quarzküvetten mit einer gesättigten Sorbit- Lösung in Methanol, der ca. 0,5 Gew.-% Benzophenon zugesetzt war, übergeführt. Das Ganze wurde dann für 48 Stunden mit einem Hg-Mitteldruckstrahler bestrahlt. - Da nach wurden die Kontaktlinsen in de-ionisiertem Wasser äquilibriert. Die derart behandelte Kontaktlinsenoberfläche ist nunmehr hydrophil, wobei diese Eigen schaft auch gegenüber Kontaktlinsenpflegemitteln ausgesprochen beständig ist.Contact lenses made of silicone rubber (from Wöhlk, Schönkirchen near Kiel) were made for exposed to gaseous vinyltrimethoxysilane for about 8 days, namely that: at 30 ° C in a polypropylene net above approx. 10 ml vinyl trimethoxysilane were positioned in a desiccator. The contact lenses were then subjected to an approximately two-hour heat treatment at approximately 70 ° C. Then they were placed in quartz cuvettes with a saturated sorbitol solution Methanol, which was added about 0.5 wt .-% benzophenone, transferred. The The whole was then irradiated with a medium pressure mercury lamp for 48 hours. - After that, the contact lenses were equilibrated in de-ionized water. The so treated contact lens surface is now hydrophilic, which is inherent shaft is also extremely resistant to contact lens care products.
Claims (2)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19732774A DE19732774A1 (en) | 1997-07-30 | 1997-07-30 | Covalent modification of compounds in liquid phase used as e.g. injectable immunogens, contact lenses or catheters |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19732774A DE19732774A1 (en) | 1997-07-30 | 1997-07-30 | Covalent modification of compounds in liquid phase used as e.g. injectable immunogens, contact lenses or catheters |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE19732774A1 true DE19732774A1 (en) | 1999-02-04 |
Family
ID=7837348
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19732774A Withdrawn DE19732774A1 (en) | 1997-07-30 | 1997-07-30 | Covalent modification of compounds in liquid phase used as e.g. injectable immunogens, contact lenses or catheters |
Country Status (1)
| Country | Link |
|---|---|
| DE (1) | DE19732774A1 (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1035175A3 (en) * | 1999-03-10 | 2001-01-03 | Wacker-Chemie GmbH | Flocculation concentrate useful for the preparation of fast-drying aqueous plaster- and coating compositions, and such compositions |
| DE102009018537A1 (en) | 2009-04-24 | 2010-10-28 | Siegel, Rolf, Dr. Med. | Use of quinazolinone derivative surface-modified silicone moldings |
-
1997
- 1997-07-30 DE DE19732774A patent/DE19732774A1/en not_active Withdrawn
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1035175A3 (en) * | 1999-03-10 | 2001-01-03 | Wacker-Chemie GmbH | Flocculation concentrate useful for the preparation of fast-drying aqueous plaster- and coating compositions, and such compositions |
| US6531538B1 (en) | 1999-03-10 | 2003-03-11 | Wacker-Chemie Gmbh | Fast-drying rendering and coating composition |
| DE102009018537A1 (en) | 2009-04-24 | 2010-10-28 | Siegel, Rolf, Dr. Med. | Use of quinazolinone derivative surface-modified silicone moldings |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69531617T3 (en) | POLYMIC MICROBUGS AND MANUFACTURING METHOD | |
| DE69018691T2 (en) | Medical arrangement with a highly biocompatible surface and method for its production. | |
| DE69231935T2 (en) | CONJUGATE CONTAINING A STRAIGHT CHAIN ORGANIC POLYMER WITH BONDED SULFATED GLUCOSAMINOGLUCANS, FOR EXAMPLE HEPARINE, ITS PRODUCTION, USE AND A CORRESPONDING SUBSTRATE | |
| DE69328523T2 (en) | IMMOBILIZATION OF A CHEMICAL SPECIES IN A NETWORKED MATRIX | |
| DE60029761T2 (en) | METHOD OF NETWORKING HYALURONIC ACID WITH POLYMERS | |
| DE3751647T2 (en) | Biodegradable microspheres as carriers for macromolecules | |
| DE69102062T2 (en) | IMMOBILIZED POLYETHYLENE OXYD STAR MOLECULES FOR ORGANIC APPLICATIONS. | |
| DE69423522T2 (en) | ACRYLNITRILE POLYMER MEMBRANE | |
| DE69330344T2 (en) | NETWORKED BIOCOMPATIBLE ENCLOSURE COMPOSITIONS AND METHODS | |
| EP0839159B1 (en) | Polysaccharide gel composition | |
| DE3785147T2 (en) | Regenerated cellulose membrane and process for its manufacture. | |
| EP0759760B1 (en) | Wound healing agent | |
| DE69126535T2 (en) | BIOCOMPATIBLE MICROCAPSULES | |
| DE3782394T2 (en) | IMMOBILIZED, PHYSIOLOGICALLY ACTIVE MATERIAL. | |
| US4356236A (en) | Spherically shaped material comprising acylated product of de-N-acetylated chitin | |
| DE2426988A1 (en) | PROCESS FOR CARRIER BINDING OF BIOLOGICALLY ACTIVE PROTEINS | |
| DE2552510C3 (en) | Biologically active compounds and processes for their preparation | |
| JPH02138346A (en) | Crosslinked hyaluronic acid gel composition and its manufacture | |
| DE68920061T2 (en) | Hydrofiles, fine gel particles and processes for their production. | |
| EP3484612A1 (en) | Chromatography medium having bonded microglobuli and method for the production thereof | |
| EP0514724A1 (en) | Powdery absorbent, for aqueous liquids, based on water-bulking polymer | |
| DE3543942A1 (en) | HYDROGELS WITH X-RAY CONTRAST, THEIR PRODUCTION AND THEIR USE | |
| DE19732774A1 (en) | Covalent modification of compounds in liquid phase used as e.g. injectable immunogens, contact lenses or catheters | |
| DE69225053T2 (en) | COMPOSITIONS BASED ON COLLAGES FOR CONTROLLED RELEASE OF MEDICINAL PRODUCTS | |
| DE2102514B2 (en) | PROCESS FOR CHEMICAL COUPLING OF BIOLOGICALLY ACTIVE SUBSTANCES TO A HYDROPHILIC POLYMER |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8139 | Disposal/non-payment of the annual fee |